Atrial fibrillation and stroke: risk stratification and new anticoagulants [0.03%]
房颤与卒中:危险分层和新的抗凝药物
Charles Jazra,Maurice Khoury
Charles Jazra
Non-antiarrhythmic drugs for the prevention of atrial fibrillation: ACEIs, ARBs, statins and PUFAs [0.03%]
非抗心律失常药物在房颤预防中的作用:血管紧张素转换酶抑制剂、血管紧张素Ⅱ受体拮抗剂、他汀及多不饱和脂肪酸
Laurent Fauchier,Bertrand Pierre,Nicolas Clementy et al.
Laurent Fauchier et al.
Jacques Mansourati,Pierre Khattar
Jacques Mansourati
Management of atrial fibrillation in the emergency department: who should be admitted? [0.03%]
急诊室中房颤的处理:谁需要住院?
Wissam Elzein,Wael Chalak,Charles Jazra
Wissam Elzein
Samer Nasr,Samer Terro
Samer Nasr
The role of multi-modality cardiac imaging in patients with atrial fibrillation [0.03%]
心房颤动患者的多模式心脏影像的作用
Wael AlJaroudi,Wael A Jaber
Wael AlJaroudi
Michel Chauvin
Michel Chauvin
Antonio Sorgente,Riccardo Cappato
Antonio Sorgente
Maurice Khoury,Charles Jazra
Maurice Khoury